Owlstone Medical Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Private

  • Employees
  • 169

Employees

  • Latest Deal Type
  • Series E

  • Latest Deal Amount
  • $31.4M

  • Investors
  • 12

Owlstone Medical General Information

Description

Developer of a healthcare breathalyzer product designed to focus on non-invasive diagnostics for the early detection of disease and on precision medicine. The company is developing a biopsy product and a proprietary sample collection device that can take stable breath samples anywhere, enabling doctors to avail detection of diseases, including lung cancer, liver disease, digestive health, and respiratory disease.

Contact Information

Formerly Known As
Tiger Dawn, Owlstone
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 183 Cambridge Science Park
  • Milton Road
  • Cambridge CB4 0GJ
  • England, United Kingdom
+44 01223
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 183 Cambridge Science Park
  • Milton Road
  • Cambridge CB4 0GJ
  • England, United Kingdom
+44 01223

Owlstone Medical Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Owlstone Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC (Series E) 25-Mar-2025 $31.4M Completed Clinical Trials - Phase 2
11. Grant 25-Feb-2024 Completed Clinical Trials - Phase 2
10. Later Stage VC 25-Feb-2024 Completed Clinical Trials - Phase 2
9. Later Stage VC (Series D) 31-Aug-2021 Completed Clinical Trials - Phase 2
8. Later Stage VC 01-Oct-2018 Completed Clinical Trials - Phase 2
7. Grant 25-Jan-2018 Completed Clinical Trials - Phase 2
6. Later Stage VC 27-Mar-2017 Completed Clinical Trials - Phase 2
5. Later Stage VC 06-Jan-2017 Completed Clinical Trials - Phase 2
4. Grant 11-Dec-2016 $1.38M $9.3M Completed Clinical Trials - Phase 2
3. Later Stage VC 28-Jun-2016 $7.27M $9.3M Completed Clinical Trials - Phase 2
To view Owlstone Medical’s complete valuation and funding history, request access »

Owlstone Medical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Convertible E
Convertible E
Convertible E
Convertible E
Convertible E
A Ordinary
D Ordinary
A Ordinary
C Ordinary 23,667 $0.000128 $16.75 $16.75 1x $16.75 0.15%
C Ordinary 1,230,770 $0.000128 $17.19 $17.19 1x $17.19 7.77%
To view Owlstone Medical’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Owlstone Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a healthcare breathalyzer product designed to focus on non-invasive diagnostics for the early detection of
Diagnostic Equipment
Cambridge, United Kingdom
169 As of 2025

Louisville, KY
 

Moncton, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Owlstone Medical Competitors (5)

One of Owlstone Medical’s 5 competitors is Breath Diagnostics, a Venture Capital-Backed company based in Louisville, KY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Breath Diagnostics Venture Capital-Backed Louisville, KY
Breathe BioMedical Venture Capital-Backed Moncton, Canada
HemoCue Corporate Backed or Acquired Ängelholm, Sweden
COSMED Venture Capital-Backed Rome, Italy
Natus Medical Private Equity-Backed Middleton, WI
You’re viewing 5 of 5 competitors. Get the full list »

Owlstone Medical Patents

Owlstone Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202417686-D0 Breath sampling device Pending 02-Dec-2024
WO-2026120265-A1 Breath sampling device Pending 02-Dec-2024
GB-202407301-D0 Diagnosis of liver disease Inactive 22-May-2024
WO-2025243037-A1 Diagnosis of liver disease Pending 22-May-2024
GB-202404341-D0 Breath analysis device Pending 26-Mar-2024 G01N33/497
To view Owlstone Medical’s complete patent history, request access »

Owlstone Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Owlstone Medical Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cystic Fibrosis Foundation Limited Partner Minority
HSBC Global Custody Nominee (UK) Other Minority
Gates Foundation Not-For-Profit Venture Capital Minority
Hon Hai Precision Industry Corporation Minority
Horizons Ventures Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Owlstone Medical FAQs

  • When was Owlstone Medical founded?

    Owlstone Medical was founded in 2003.

  • Where is Owlstone Medical headquartered?

    Owlstone Medical is headquartered in Cambridge, United Kingdom.

  • What is the size of Owlstone Medical?

    Owlstone Medical has 169 total employees.

  • What industry is Owlstone Medical in?

    Owlstone Medical’s primary industry is Diagnostic Equipment.

  • Is Owlstone Medical a private or public company?

    Owlstone Medical is a Private company.

  • What is the current valuation of Owlstone Medical?

    The current valuation of Owlstone Medical is .

  • What is Owlstone Medical’s current revenue?

    The current revenue for Owlstone Medical is .

  • How much funding has Owlstone Medical raised over time?

    Owlstone Medical has raised $213M.

  • Who are Owlstone Medical’s investors?

    Cystic Fibrosis Foundation, HSBC Global Custody Nominee (UK), Gates Foundation, Hon Hai Precision Industry, and Horizons Ventures are 5 of 12 investors who have invested in Owlstone Medical.

  • Who are Owlstone Medical’s competitors?

    Breath Diagnostics, Breathe BioMedical, HemoCue, COSMED, and Natus Medical are competitors of Owlstone Medical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process